ArticleBMJ open2022

PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials.

Jichang Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.